Pocket Knife Software Launches ANNIE AI Trading Platform to Public After Years of Private Development
Unlike traditional predictive models, ANNIE employs a hybrid of neural networks and genetic algorithms to evolve trading strategies based solely on real-world performance, leveraging real-world trading data since April 2024. The AI reviews over 1,200 U.S. equities daily and generates trade recommendations designed for consistency rather than speculation. Recent iterations of ANNIE have demonstrated performance levels approximately twice as strong as earlier versions, according to Pocket Knife Software's internal data.
"ANNIE isn't trying to guess where the market is going tomorrow," said Rick Cockerham, creator of ANNIE and founder of Pocket Knife Software. "It's designed to make sound trading decisions based on what works, using evolved strategies that continuously adapt to changing market conditions".
And when ANNIE gives out recommendations, they're exactly that. Because ANNIE delivers trade ideas – not automated trades – users stay in control of their money, their account, and their decisions.
Originally conceived while Cockerham was studying AI at Iowa State University in the 1990s, ANNIE has undergone years of iteration. These iterations led him to make ANNIE available to other independent investors seeking an alternative to traditional financial services.
The subscription service delivers daily buy and sell signals through email or text message approximately one hour before market close. Subscribers maintain full control over their investment accounts, allowing them to manually execute trades based on ANNIE's recommendations. The platform also includes portfolio tracking and risk management signals such as stop-loss alerts.
'Most AI stock pickers rely on predictive models that can't consistently outperform the market,' said Rick. 'ANNIE is different because it evolves – discarding what doesn't work and refining what does through live market results. That evolutionary engine is what sets ANNIE apart'.
ANNIE's public release comes at a time when individual investors face mounting challenges competing against institutional capital and increasingly complex markets. Cockerham emphasizes that the platform is designed for serious, self-directed investors seeking a transparent and disciplined system that complements their own trading decisions.
About Pocket Knife Software Founded by Rick Cockerham, Pocket Knife Software develops AI-powered financial tools for independent investors. The company's flagship product, ANNIE, combines neural networks and genetic algorithms to evolve trading strategies based on real-world market performance. Operating from Austin, Texas, Pocket Knife Software is committed to making hedge-fund-grade technology accessible to self-directed investors. Learn more at AI-StockTrading.com.
Press inquiries
Pocket Knife Software https://www.ai-stocktrading.com/ Rick Cockerham rick@pocketknifesoftware.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Asian Penny Stocks To Monitor In July 2025
As global markets experience varied performances, with the U.S. indices hitting record highs and Japan facing trade negotiation challenges, investors are keenly observing the shifting dynamics in Asia. Amidst these developments, penny stocks—traditionally smaller or newer companies—continue to capture attention for their potential value and growth opportunities. While the term may seem outdated, these stocks still hold relevance as they often represent companies with solid financial foundations that could offer stability and potential upside in a fluctuating market landscape. Name Share Price Market Cap Financial Health Rating Lever Style (SEHK:1346) HK$1.29 HK$813.93M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$2.08 HK$3.6B ★★★★★☆ TK Group (Holdings) (SEHK:2283) HK$2.28 HK$1.9B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.43 SGD174.27M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.14 HK$1.9B ★★★★★★ T.A.C. Consumer (SET:TACC) THB4.42 THB2.65B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.21 SGD8.7B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.92 THB1.35B ★★★★★★ Beng Kuang Marine (SGX:BEZ) SGD0.20 SGD40.44M ★★★★★★ BRC Asia (SGX:BEC) SGD3.16 SGD866.95M ★★★★★★ Click here to see the full list of 993 stocks from our Asian Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★★★ Overview: PSG Corporation Public Company Limited, with a market cap of THB14.79 billion, operates in turnkey engineering, procurement, and construction (EPC) and large-scale construction projects in Thailand and the Lao People's Democratic Republic. Operations: The company's revenue is primarily derived from its plant and building construction segment, amounting to THB2.82 billion. Market Cap: THB14.79B PSG Corporation, with a market cap of THB14.79 billion, operates in the EPC and construction sectors in Thailand and Laos. Despite being debt-free and having short-term assets significantly exceeding liabilities, PSG's earnings have declined substantially over the past year, with revenue dropping to THB642.96 million from THB1.49 billion a year ago. The company's net profit margin has also decreased from 51.6% to 26.8%. Recent volatility in share price could be attributed to these financial results and strategic moves like the recent MOU with Electricite du Laos for renewable energy projects, potentially enhancing future growth prospects amidst current challenges. Navigate through the intricacies of PSG Corporation with our comprehensive balance sheet health report here. Evaluate PSG Corporation's historical performance by accessing our past performance report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: CSE Global Limited is an investment holding company that provides integrated industrial automation, information technology, and intelligent transport solutions across the Asia Pacific, the Americas, Europe, the Middle East, and Africa with a market cap of SGD436.54 million. Operations: The company's revenue is derived from three primary segments: Automation (SGD194.36 million), Communications (SGD232.04 million), and Electrification (SGD434.78 million). Market Cap: SGD436.54M CSE Global Limited, with a market cap of SGD436.54 million, shows a stable financial foundation with short-term assets exceeding liabilities and well-covered interest payments by EBIT. Despite experiencing a 5.4% annual decline in earnings over the past five years, recent profit growth of 16.9% signals potential recovery, outpacing industry averages. The company's seasoned management and board add strategic depth, further enhanced by the recent appointment of Mr. Ravinder Singh as Non-Executive Director to bolster governance capabilities. However, dividend sustainability remains questionable due to insufficient free cash flow coverage despite trading below estimated fair value. Click here to discover the nuances of CSE Global with our detailed analytical financial health report. Assess CSE Global's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zhejiang CONBA Pharmaceutical Co., Ltd. focuses on the research, development, production, and sales of pharmaceuticals and health products in mainland China, with a market cap of CN¥11.27 billion. Operations: The company's revenue primarily comes from its operations in China, totaling CN¥6.38 billion. Market Cap: CN¥11.27B Zhejiang CONBA Pharmaceutical Co., Ltd. demonstrates a solid financial position with short-term assets of CN¥4.5 billion surpassing both short and long-term liabilities, and its debt is well-covered by operating cash flow. Despite a slight decline in quarterly revenue to CN¥1.68 billion, the company maintains profitability with net income at CN¥189.4 million and improved profit margins from 8.1% to 9.3%. However, its return on equity remains low at 8.7%, and the board's average tenure suggests inexperience, potentially impacting strategic decisions amidst an unstable dividend track record despite trading below estimated fair value by 16.6%. Dive into the specifics of Zhejiang CONBA PharmaceuticalLtd here with our thorough balance sheet health report. Examine Zhejiang CONBA PharmaceuticalLtd's past performance report to understand how it has performed in prior years. Navigate through the entire inventory of 993 Asian Penny Stocks here. Want To Explore Some Alternatives? We've found 16 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SET:PSG SGX:544 and SHSE:600572. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Bloomberg
33 minutes ago
- Bloomberg
Bloomberg Daybreak Asia: Tariffs, Asia Week Ahead
Major US trading partners hurried over the weekend to secure trade deals or lobby for extra time, while Treasury Secretary Scott Bessent indicated that some countries lacking an agreement by the deadline Wednesday will have the option of a three-week extension to negotiate. Also, central banks in Australia, South Korea, and Malaysia are expected to keep interest rates on hold in the week ahead. We speak to Paul Dobson, Bloomberg's Executive Editor for Asia Markets. Plus - for more insight on President Trump's tariff deadline nearing, and the economic week ahead for Asia, we heard from Trinh Nguyen, Natixis Senior Emerging Asia Economist.
Yahoo
36 minutes ago
- Yahoo
Gold Eases Lower as Traders Seek Clarity on US Trade Deal Talks
(Bloomberg) -- Gold eased after gaining nearly 2% last week, as investors awaited developments in US trade negotiations ahead of a July 9 tariff deadline set by President Donald Trump. Foreign Buyers Swoop on Cape Town Homes, Pricing Out Locals Trump's Gilded Design Style May Be Gaudy. But Don't Call it 'Rococo.' Massachusetts to Follow NYC in Making Landlords Pay Broker Fees NYC Commutes Resume After Midtown Bus Terminal Crash Chaos What Gothenburg Got Out of Congestion Pricing Bullion traded near $3,325 an ounce, with Treasury Secretary Scott Bessent indicating a possible extension to talks, saying that some countries lacking an agreement by Wednesday will have a three-week window to continue discussions. Many major US trading partners are hurrying to secure deals or lobby for extra time, with Commerce Secretary Howard Lutnick telling reporters on Sunday that country-by-country tariffs will take effect Aug. 1. Trump has long threatened that if countries fail to reach deals by July 9, he would impose higher rates on them. Concerns about the potential for a growing US-led trade war have underscored gold's appeal as a haven asset. Bullion is up by more than a quarter this year, trading about $170 shy of a record set in April, with investors seeking safety in the metal amid heightened geopolitical and trade tensions. Inflows into bullion-backed exchange-traded funds have helped support the rally, alongside ongoing strong demand from global central banks. Spot gold was down 0.4% to $3,325.05 an ounce as of 8:10 a.m. in Singapore. The Bloomberg Dollar Spot Index dipped, following a weekly loss of 0.4%. Silver, palladium and platinum were all little changed. For Brazil's Criminals, Coffee Beans Are the Target SNAP Cuts in Big Tax Bill Will Hit a Lot of Trump Voters Too Sperm Freezing Is a New Hot Market for Startups Pistachios Are Everywhere Right Now, Not Just in Dubai Chocolate China's Homegrown Jewelry Superstar ©2025 Bloomberg L.P.
